论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
抗肿瘤治疗前的血清钙水平可预测鼻咽癌患者的临床结果
Authors Huang SY, Chen Y, Tan XR, Gong S, Yang XJ, He QM, He SW, Liu N, Li YQ
Received 5 August 2020
Accepted for publication 9 October 2020
Published 23 December 2020 Volume 2020:13 Pages 13111—13119
DOI https://doi.org/10.2147/OTT.S275613
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Prof. Dr. Nicola Silvestris
Purpose: The prognostic value of serum calcium levels in nasopharyngeal carcinoma (NPC) remains unknown. This study aimed to evaluate the prognostic value of serum calcium levels in patients with NPC.
Patients and Methods: A total of 2094 patients diagnosed with NPC between April 2009 and September 2012 were enrolled in this retrospective analysis. The median follow-up time was 96.3 months (range: 4.1– 120.0 months). Univariate and multivariable Cox proportional hazards models were used to identify significant and independent prognostic predictors of overall survival (OS), disease-free survival (DFS), distant metastasis-free survival (DMFS), and relapse-free survival (RFS).
Results: Overall, low serum calcium levels were detected in 1109/2094 (53.00%) patients and tended to be more frequently detected in older (P < 0.001) and female (P =0.001) patients. Patients with low serum calcium levels had poorer OS (P =0.011), DFS (P =0.012) and DMFS (P =0.004) than those with high serum calcium levels, but serum calcium levels had no significant effect on RFS (P =0.376). In univariate and multivariable analyses, low serum calcium levels were a statistically significant and independent prognostic factor for OS, DFS, and DMFS but had no prognostic value for RFS.
Conclusion: Serum calcium levels can serve as a prognostic predictor and guide more individualized treatment for NPC patients.
Keywords: nasopharyngeal carcinoma, serum calcium level, prognosis, survival